Posted by Michael Wonder on 19 Dec 2022
Drug pricing reform in the Inflation Reduction Act: what are the implications? Part 1
14 December 2022 - The Inflation Reduction Act, signed by President Biden on 16 August 2022, is the most substantial drug payment and coverage legislation enacted since the Medicare Modernization Act of 2003, which created Medicare Part D and made important changes to the way physician-administered drugs are reimbursed in Medicare Part B.
Due to the budget reconciliation process requiring a direct impact on the Federal budget or revenue, provisions related to commercial markets were struck from the final version of the Inflation Reduction Act, and thus its drug pricing provisions pertain directly only to Medicare.
